Mesoblast Ltd
NASDAQ:MESO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mesoblast Ltd
NASDAQ:MESO
|
AU |
|
L
|
Lynas Rare Earths Ltd
XBER:LYIC
|
MY |
|
S
|
Societe Generale SA
OTC:SCGLF
|
FR |
|
A
|
Applied Materials Inc
DUS:AP2
|
US |
|
Nuvei Corp
F:62E
|
CA |
|
LiveOne Inc
F:351
|
US |
|
Li Auto Inc
OTC:LAAOF
|
CN |
|
Carel Industries SpA
F:CIG
|
IT |
|
L
|
Liberty Global PLC
NASDAQ:LBTYK
|
UK |
|
J
|
Japan Display Inc
XMUN:1J4
|
JP |
|
MERLIN Properties SOCIMI SA
LSE:0QVM
|
ES |
|
N
|
Nikkon Holdings Co Ltd
OTC:NIPKF
|
JP |
|
A
|
Ameriprise Financial Inc
SWB:A4S
|
US |
|
A
|
ALD SA
SWB:3AL
|
FR |
|
C
|
CF Industries Holdings Inc
F:C4F
|
US |
|
CVB Financial Corp
NASDAQ:CVBF
|
US |
|
Legrand SA
LSE:0MW7
|
FR |
|
Canon Electronics Inc
OTC:CAOEF
|
JP |
|
B
|
Barrick Gold Corp
SWB:ABR
|
CA |
|
B
|
Bunge Ltd
F:BU3
|
US |
Bankruptcy Probability
Mesoblast Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Mesoblast Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Mesoblast Ltd
ASX:MSB
|
2.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
430.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
219B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Mesoblast Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Mesoblast Ltd has total debt of 66m USD. This includes both short-term (0 USD) and long-term (66m USD) debt.
You can find a full breakdown on its Balance Sheet.
